ADRB3 and T-cell non-Hodgkin lymphoma: Among different tumor specimens, higher levels of β3-AR were detected in melanoma and moderate levels of expression were observed across cancer tissues such as thyroid papillary carcinoma and T-cell lymphoma [17].